These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19713713)

  • 1. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors.
    Eriksson B; Annibale B; Bajetta E; Mitry E; Pavel M; Platania M; Salazar R; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):214-9. PubMed ID: 19713713
    [No Abstract]   [Full Text] [Related]  

  • 2. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.
    Oberg K; Ferone D; Kaltsas G; Knigge UP; Taal B; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):209-13. PubMed ID: 19077379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of digestive neuroendocrine tumors].
    Rougier P; Toma C; Fabri MC; Ducreux M
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):117-20. PubMed ID: 7618833
    [No Abstract]   [Full Text] [Related]  

  • 4. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
    Kwekkeboom DJ; Krenning EP; Lebtahi R; Komminoth P; Kos-Kudła B; de Herder WW; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):220-6. PubMed ID: 19713714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interferon and 5-fluorouracil on serum VEGF levels in neuroendocrine tumours.
    Van Der Horst-Schrivers AN; Slot MH; Willemse PH; Kema IP; De Vries EG; Wymenga AN
    Acta Oncol; 2008; 47(1):153-5. PubMed ID: 17851877
    [No Abstract]   [Full Text] [Related]  

  • 6. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
    Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroendocrine tumors (NETs).
    Bajetta E; Procopio G; Guadalupi V; Del Vecchio M
    Clin Ther; 2009 Sep; 31(9):2060-1. PubMed ID: 19843495
    [No Abstract]   [Full Text] [Related]  

  • 8. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.
    Arnold R; Chen YJ; Costa F; Falconi M; Gross D; Grossman AB; Hyrdel R; Kos-Kudła B; Salazar R; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):227-33. PubMed ID: 19713715
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical oncology considerations in patients with metastatic neuroendocrine carcinomas.
    Kvols L
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):56-60. PubMed ID: 7992083
    [No Abstract]   [Full Text] [Related]  

  • 10. Current Chemotherapy Use in Neuroendocrine Tumors.
    Chan DL; Singh S
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):603-614. PubMed ID: 30098718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.
    O'Toole D; Grossman A; Gross D; Delle Fave G; Barkmanova J; O'Connor J; Pape UF; Plöckinger U; ;
    Neuroendocrinology; 2009; 90(2):194-202. PubMed ID: 19713711
    [No Abstract]   [Full Text] [Related]  

  • 12. ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors.
    Plöckinger U; Wiedenmann B; de Herder WW
    Neuroendocrinology; 2009; 90(2):159-61. PubMed ID: 19713708
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroendocrine tumors: novel approaches in the age of targeted therapy.
    Phan AT; Yao JC
    Oncology (Williston Park); 2008 Dec; 22(14):1617-23; discussion 1623-4, 1629. PubMed ID: 19198220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine tumor of the rectum.
    Suyama K; Hayashi N; Shigaki H; Sato N; Hirashima K; Nagai Y; Hiyoshi Y; Sakamoto Y; Yoshida N; Toyama E; Watanabe M; Baba H
    Am J Surg; 2009 Sep; 198(3):e39-41. PubMed ID: 19716878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors. Biotherapy.
    Plöckinger U; Wiedenmann B
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):145-62. PubMed ID: 17382270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Criteria for the determination of the efficacy of solid cancer chemotherapy].
    Saito T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):626-34. PubMed ID: 3954385
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the activity of temsirolimus in neuroendocrine cancer.
    O'Donnell PH; Ratain MJ
    Br J Cancer; 2007 Jan; 96(1):177; author reply 178-9. PubMed ID: 17164757
    [No Abstract]   [Full Text] [Related]  

  • 19. ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. Introduction.
    O'Toole D; Rindi G; Plöckinger U; Wiedenmann B;
    Neuroendocrinology; 2010; 91(4):324-5. PubMed ID: 20407213
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroendocrine tumours: a hope and a prayer.
    Grossman A
    Gut; 2009 Feb; 58(2):164-5. PubMed ID: 19136520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.